Should I buy or sell P3 Health Partners stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for P3 Health Partners in the last twelve months. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" PIII shares. View PIII analyst ratings or view top-rated stocks .

What is P3 Health Partners' stock price target for 2024?

4 equities research analysts have issued 12 month price objectives for P3 Health Partners' stock. Their PIII share price targets range from $4.50 to $5.00. On average, they predict the company's share price to reach $4.75 in the next year. This suggests a possible upside of 839.5% from the stock's current price. View analysts price targets for PIII or view top-rated stocks among Wall Street analysts .

How have PIII shares performed in 2024?

P3 Health Partners' stock was trading at $1.41 at the start of the year. Since then, PIII shares have decreased by 64.1% and is now trading at $0.5056. View the best growth stocks for 2024 here .

When is P3 Health Partners' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024. View our PIII earnings forecast .

What guidance has P3 Health Partners issued on next quarter's earnings?

P3 Health Partners issued an update on its FY 2024 earnings guidance on Thursday, March, 28th. The company provided EPS guidance of for the period. The company issued revenue guidance of $1.5 billion-$1.6 billion, compared to the consensus revenue estimate of $1.4 billion.

How do I buy shares of P3 Health Partners?

Shares of PIII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:PIII

P3 Health Partners (PIII) Stock Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Free PIII Stock Alerts

$0.51

0.00 (0.00%)

(As of 04/19/2024 ET)

Compare

Today's Range: $0.50
▼
$0.53
50-Day Range: $0.47
▼
$1.16
52-Week Range: $0.45
▼
$5.56

Volume: 243,242 shs
Average Volume: 371,636 shs
Market Capitalization: $159.72 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $4.75

Get P3 Health Partners alerts:

P3 Health Partners MarketRank™ Stock Analysis

Analyst Rating: Moderate Buy
2.50 Rating Score
Upside/Downside: 839.5% Upside
$4.75 Price Target
Short Interest: Bearish
4.48% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($0.56) to ($0.49) Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.87 out of 5 stars

Medical Sector

810th out of 911 stocks

Health Services Industry

9th out of 10 stocks

3.3

Analyst's Opinion

Consensus Rating
P3 Health Partners has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings.
Amount of Analyst Coverage
P3 Health Partners has only been the subject of 3 research reports in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
4.48% of the float of P3 Health Partners has been sold short.
Short Interest Ratio / Days to Cover
P3 Health Partners has a short interest ratio ("days to cover") of 5.8.
Change versus previous month
Short interest in P3 Health Partners has recently increased by 4.39%, indicating that investor sentiment is decreasing.

0.0

Dividend Strength

Dividend Yield
P3 Health Partners does not currently pay a dividend.
Dividend Growth
P3 Health Partners does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for PIII.

0.6

News and Social Media Coverage

News Coverage This Week
MarketBeat has tracked 1 news article for P3 Health Partners this week, compared to 1 article on an average week.
Search Interest
Only 2 people have searched for PIII on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
MarketBeat Follows
5 people have added P3 Health Partners to their MarketBeat watchlist in the last 30 days. This is an increase of 150% compared to the previous 30 days.

0.8

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, P3 Health Partners insiders have not sold or bought any company stock.
Percentage Held by Insiders
17.06% of the stock of P3 Health Partners is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 7.75% of the stock of P3 Health Partners is held by institutions.

0.6

Earnings and Valuation

Earnings Growth
Earnings for P3 Health Partners are expected to grow in the coming year, from ($0.56) to ($0.49) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of P3 Health Partners is -0.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of P3 Health Partners is -0.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
P3 Health Partners has a P/B Ratio of 1.12. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Crypto 101 Media

SHOCKING Crypto Leak…

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

About P3 Health Partners Stock (NASDAQ:PIII)

P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.

PIII Stock Price History

30 days | 90 days | 365 days | Advanced Chart

PIII Stock News Headlines

April 19, 2024 | americanbankingnews.com

CareRx (OTCMKTS:CHHHF) versus P3 Health Partners (NASDAQ:PIII) Financial Survey

April 3, 2024 | businesswire.com

P3 Health Partners to Present at the 23rd Annual Needham Virtual Healthcare Conference

April 19, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

March 28, 2024 | benzinga.com

P3 Health Partners: Q4 Earnings Insights

March 28, 2024 | finance.yahoo.com

P3 Health Partners Inc. Reports Revenue Growth and Affirms 2024 Guidance, Despite Net Loss

March 28, 2024 | businesswire.com

P3 Health Partners Announces Fourth Quarter and Full Year 2023 Results

March 17, 2024 | uk.investing.com

P3 Health to report Q4 and full year 2023 earnings on March 28

February 28, 2024 | businesswire.com

P3 Health Partners to Participate in the Jefferies Value Based Healthcare Summit

April 19, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

February 19, 2024 | businesswire.com

P3 Health Partners to Present at the TD Cowen 44th Annual Healthcare Conference

January 30, 2024 | finance.yahoo.com

P3 Health Partners to Participate in The 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

January 19, 2024 | finance.yahoo.com

P3 Health Partners Inc.'s (NASDAQ:PIII) Path To Profitability

January 10, 2024 | msn.com

P3 Health Partners reaffirms 2023 guidance, sees 2024 revenue above estimates

January 10, 2024 | markets.businessinsider.com

Why Health Management Company P3 Health Partners Shares Are Up Today

January 9, 2024 | markets.businessinsider.com

P3 Health Partners Reaffirms 2023 Guidance, Sees 2024 Revenue Above View; Stock Up

January 9, 2024 | finance.yahoo.com

P3 Health Partners Reaffirms Guidance for 2023 and Announces Guidance for 2024

January 2, 2024 | finance.yahoo.com

P3 Health Partners to Present at the 42nd Annual J.P. Morgan Healthcare Conference

December 17, 2023 | morningstar.com

P3 Health Partners Inc Class A PIII

November 15, 2023 | markets.businessinsider.com

Positive Revenue Prospects and Improved Cash Flow: Reasons Behind David Larsen’s Buy Rating for P3 Health Partners

November 12, 2023 | finance.yahoo.com

P3 Health Partners Inc. (NASDAQ:PIII) Q3 2023 Earnings Call Transcript

November 8, 2023 | businesswire.com

55,508

November 8, 2023 | finance.yahoo.com

P3 Health Partners Announces Third-Quarter and Year-to-Date 2023 Results

November 3, 2023 | finance.yahoo.com

P3 Health Partners Schedules Third-Quarter 2023 Earnings Release and Conference Call

October 29, 2023 | finance.yahoo.com

Several Insiders Invested In P3 Health Partners Flagging Positive News

October 20, 2023 | money.usnews.com

P3 Health Partners Inc - Ordinary Shares - Class A

October 6, 2023 | uk.investing.com

P3 Health Partners Recent Insider Activity

October 4, 2023 | benzinga.com

P3 Health Partners 10% Owner Trades $186K In Company Stock

See More Headlines

Receive PIII Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for P3 Health Partners and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/19/2024
Next Earnings (Estimated): 5/08/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Health services
Sub-Industry: N/A
Current Symbol: NASDAQ:PIII
CUSIP: N/A
CIK: 1832511
Web: foresightacq.com
Phone: 702-910-3950
Fax: N/A
Employees: 400
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $4.75
High Stock Price Target: $5.00
Low Stock Price Target: $4.50
Potential Upside/Downside: +849.8%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.50
Research Coverage: 4 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.65)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-57,770,000.00
Net Margins: -4.56%
Pretax Margin: -14.51%
Return on Equity: -120.85%
Return on Assets: -6.54%

Debt

Debt-to-Equity Ratio: 0.76
Current Ratio: 0.55
Quick Ratio: 0.55

Sales & Book Value

Annual Sales: $1.27 billion
Price / Sales: 0.12
Cash Flow: $0.09 per share
Price / Cash Flow: 5.31
Book Value: $0.45 per share
Price / Book: 1.11

Miscellaneous

Outstanding Shares: 315,900,000
Free Float: 262,010,000
Market Cap: $157.98 million
Optionable: Not Optionable
Beta: 1.04

The Best High-Yield Dividend Stocks for 2024

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

Dr. Sherif Abdou F.A.C.E.P. (Age 63)
FACP, M.D., Co-Founder, CEO & Director
Comp: $7.1M
Dr. Amir Bacchus M.B.A. (Age 59)
M.D., Co-Founder, Chief Medical Officer & Director
Comp: $4.3M
Mr. Atul Kavthekar
CFO & Chief Accounting Officer
Mr. William Bettermann
Executive VP & COO
Mr. Devery Goodey
Senior Vice President of Technology
Roy Youngblood
Director of Compliance
Leslie Fisher
Senior VP of Legal Affairs & General Counsel
Ms. Kassi Belz APR
Executive Vice President of Communications, Culture & Engagement
Mr. Todd Lefkowitz MHA
Chief Managed Care Officer
Ms. Sarah Bussmann B.S.N.
CRNI, M.H.A., R.N., Chief of Staff

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

PIII Stock Analysis - Frequently Asked Questions

Should I buy or sell P3 Health Partners stock right now?: 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for P3 Health Partners in the last twelve months. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" PIII shares.
View PIII analyst ratings or view top-rated stocks.
What is P3 Health Partners' stock price target for 2024?: 4 equities research analysts have issued 12 month price objectives for P3 Health Partners' stock. Their PIII share price targets range from $4.50 to $5.00. On average, they predict the company's share price to reach $4.75 in the next year. This suggests a possible upside of 839.5% from the stock's current price.
View analysts price targets for PIII or view top-rated stocks among Wall Street analysts.
How have PIII shares performed in 2024?: P3 Health Partners' stock was trading at $1.41 at the start of the year. Since then, PIII shares have decreased by 64.1% and is now trading at $0.5056.
View the best growth stocks for 2024 here.
When is P3 Health Partners' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024.
View our PIII earnings forecast.

What guidance has P3 Health Partners issued on next quarter's earnings?: P3 Health Partners issued an update on its FY 2024 earnings guidance on Thursday, March, 28th. The company provided EPS guidance of for the period. The company issued revenue guidance of $1.5 billion-$1.6 billion, compared to the consensus revenue estimate of $1.4 billion.
How do I buy shares of P3 Health Partners?: Shares of PIII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:PIII) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

P3 Health Partners (PIII) Stock Price, News & Analysis

P3 Health Partners MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About P3 Health Partners Stock (NASDAQ:PIII)

PIII Stock Price History

PIII Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

PIII Stock Analysis - Frequently Asked Questions

Overall MarketRank^™